We have tested the hypothesis that in vitro exposure of insulin-resistant adipocytes with insulin results in improved insulin action. A primary culture system of adipocytes from obese subjects with or without non-insulin-dependent diabetes mellitus (NIDDM) and nonobese control subjects has been developed. The adipocytes when cultured in serum-free medium do not lose their original characteristics in regard to insulin binding and glucose transport. The adipocytes from three groups were incubated with insulin (0, 10-10 M, and lo-7 M) for 24 h at 370C, receptor-bound insuMin was dissociated, and basal and insulin (1 X 10-11_10-7 M)-stimulated glucose transport and "2I-insulin binding were determined. The 24-h insulin exposure of adipocytes from control subjects decreased basal and insulin-stimulated glucose transport. The effects of 1 X 1o-7 M insulin were more pronounced than 1 X 10-l' M insulin. Similarly, insulin exposure decreased insulin sensitivity and responsiveness of cultured adipocytes from obese and NIDDM patients. The insulin-induced reduction in insulin sensitivity and responsiveness for glucose transport in three groups were due to alterations at insulin binding and postbinding levels. In conclusion, insulin induces insulin resistance in control adipocytes and further worsens the insulin resistance of adipocytes from obese and NIDDM subjects. For insulin to improve the insulin resistance of adipocytes from NIDDM patients, either more prolonged in vitro insulin exposure and/or other hormonal factors might be required.
Introduction
Insulin resistance in obesity and non-insulin-dependent diabetes mellitus (NIDDM)' is characterized at the cellular level This paper was presented in part at the joint conference of the American Diabetes Association and the North American Association for the Study of Obesity, Toronto, Canada, 1985. by both binding and postbinding defects. The overall insulin resistance in NIDDM, with or without obesity, has been well demonstrated with the use of several in vivo techniques (1) (2) (3) (4) (5) (6) . Insulin therapy of NIDDM subjects improves insulin sensitivity and responsiveness of peripheral glucose utilization as assessed by glucose clamp techniques (7) (8) (9) . Several ofthe abnormalities of carbohydrate and lipid metabolism in isolated adipocytes from NIDDM patients have also been shown to improve with insulin treatment (10, 1 1). These in vivo and in vitro studies suggest that insulin improves the insulin sensitivity and responsiveness ofperipheral tissues. Enhanced insulinstimulated glucose transport with decreased or unaltered sensitivity have also been reported in isolated adipocytes from experimentally induced chronic hyperinsulinemic rats (12) (13) (14) or hyperinsulinemic young obese Zucker rats (15, 16) . Thus, it is likely that insulin sensitizes the insulin-resistant adipocytes. Whereas, it desensitizes the normal adipocytes and the evidence to support this contention is overwhelming in various animal cell models (17) (18) (19) (20) (21) (22) (23) (24) . To test these hypotheses directly, we have developed a primary culture system for insulin-responsive human adipocytes from control and morbidly obese subjects with or without NIDDM. Using this system, we de- termined the effects of a 24-h exposure of 1 X 10-10 and 1 X 10-7 M insulin on insulin sensitivity and responsiveness of glucose transport and insulin binding. (25) . Crystalline porcine insulin was kindly provided by Dr. Ronald Chance of Eli Lilly & Co., Indianapolis, IN. All other chemicals were reagent grade.
Human subjects. 16 morbidly obese patients with NIDDM and an equal number of morbidly obese patients without diabetes were studied. The clinical and biochemical data ofthese patients are presented in Table I . These patients were admitted to the hospital to undergo gastric bypass for the treatment of morbid obesity. Nonobese-nondiabetic subjects were used as the control group. These subjects had uncomplicated gallstone disease and were admitted for elective cholecystectomy, or were patients undergoing abdominal hysterectomy. The biochemical data ofthese two clinically different subgroups ofnonobese subjects were identical. Thus, they have been combined and referred to as the control group. The characteristics ofthe control group were as follows: age, 37.3±2.8 yr, sex, three male, fifteen female; weight, 65.8±2.4 kg; height, 163±6 cm; fasting plasma glucose, 96±3 mg/dl; and fasting plasma insulin, 12±2 ,U/ml. The mean fat cell colume was 374±30 pl. With the exception of the obesity and NIDDM, none of the subjects studied had any diseases or had taken any medications known to alter carbohydrate metabolism.
All subjects had maintained constant body weight during the months preceding admission. Records of food intake of the morbidly obese patients demonstrate that 15% of the calories were derived from proteins, 39% from fat, and 49% from carbohydrates, which is the typical distribution of calories for this population of patients in North Carolina (26) . Because of the effect that the caloric intake and its distribution might have on this study, morbidly obese patients studied were admitted into the hospital 4 (28) . Eight of these subjects had the intravenous GTT repeated the 3rd d of their hospitalization, while they were on a controlled diet as described above. Insulin or oral hypoglycemic agents were discontinued before admission into the hospital. Rapid-acting insulin was used only if the preprandial plasma glucose was > 300 mg/dl. The subjects underwent surgery after an overnight fast. General anesthesia was induced with a short-acting barbiturate, and maintained by phentanyl and nitrous oxide-oxygen mixture. Only saline was given intravenously before the subcutaneous fat biopsy. After exploring the abdomen, -10 g subcutaneous fat was obtained through midline incision. Informed written consent was obtained from all patients after the nature and potential risks of the study had been explained.
Isolation of human adipocytes. Isolated human adipocytes were prepared by the collagenase digestion method ofRodbell (29) , as modified for human adipose tissue by Pedersen et al. (30) . Since in many experiments we maintained isolated human adipocytes in primary culture for 24 h, the entire procedure of cell isolation was performed under strict sterile conditions. The fat biopsy was transferred from the surgical unit to the laboratory in 3% BSA-medium 199 containing penicillin (100 U/ml) and streptomycin (100 .g/ml). The tissue was washed three times in sterile phosphate-buffered saline and the majority of the connective tissue and blood clots were removed. The tissue was cut into small pieces of -1 X 2 mm size and suspended in 10 mM Hepes-Kreb's-Ringer bicarbonate (KRB) buffer (pH 7.4) containing 3% BSA, 5 mM glucose, and 0.5 mg/ml collagenase in plastic Erlenmeyer flasks. The ratio of tissue and collagenase buffer was 1:2 wt/vol. The tissue was gently digested for 45-60 min in an Orbit water bath shaken at 150-160 cycle/min at 370C in a 95% 02/5% CO2 atmosphere. After digestion, the suspension was filtered twice through nylon mesh and washed four times with 10 mM Hepes-KRB buffer (pH 7.4) containing 3% BSA and 5 mM glucose. The washing was performed by allowing the cells to settle under gravity, and the buffer was removed using a 3 1/4" spinal needle or by 5-s centrifugation at 50 rpm in a Dynac centrifuge. The cells were finally suspended at 50% lipocrit in the assay buffer. The adipocytes were fixed at 10% lipocrit in 10% formalin-buffered saline for 24 h. 5-jd aliquots of fixed cells were counted and diameter of cells was determined using a grid in the eyepiece of the microscope. The mean cell diameter and cell volume were calculated by computer analysis using average diameter and its standard deviation (31) . Since these data were not immediately available, the experiments were performed based on percent lipocrit of cell suspension.
We have tested several batches of collagenase from Sigma Chemical Co., St. Louis, MO, and Worthington Biochemical Corp., Freehold, NJ. Collagenase (Worthington Biochemical Corp.), type I (batch 43 B 216), gave maximally insulin-responsive adipocytes for glucose transport. With this particular batch of collagenase (0.5 mg/ml), digestion of fat tissue was complete and the lysis, as evidenced by the ratio of floating triglycerides and intact cell volume, was negligible (< 5%) in both control as well as fat tissue from morbidly obese patients. No preferential breakage oflarger fat cells during the isolation procedure seemed to occur as the ratio of mean fat cell volume between control (376±30 pl) and morbidly obese (790±54 pl) subjects was similar to those reported by Hirsch and Batchelor (32) in the intact adipose tissue pieces between nonobese and morbidly obese subjects.
Glucose transport in adipocytes. Glucose transport in fat cells was measured by determining the uptake of ['4C-U]glucose at tracer concentrations as described by Kashiwagi and co-workers (33) . These investigators have validated this method for measuring glucose transport in comparison to 3-0-methyl glucose uptake in nondiabetic as well as in diabetic subjects (1 1) . The basal and insulin (10`0 and l0-7 M)-stimulated glucose transport measured by two different isotopes, i.e.,
['4C-U]glucose (33) and ['4C-3-O-methyl]glucose (34) were comparable in our morbidly obese subjects with or without NIDDM. The fat cells at 20% lipocrit ( 200,000 cells/ml) were incubated with 500 nM ['4C-U]glucose in the absence and presence of varying insulin concentration (1 X 10-"-10-7 M), for 1 h at 37°C in a 95% 02/5% CO2 atmosphere in 10 mM Hepes-KRB buffer (pH 7.4) containing 3% BSA. The cells were then separated by centrifuging through silicone oil and '4C-radioactivity associated with cells was counted.
Insulin binding in adipocytes. Insulin was radiolabeled with 1251I-Na using chloramine T according to the method of Cuatrecasas (35) . The method for determining specific '251-insulin binding in human adipocytes was essentially similar to that described by Olefsky (36) . The freshly isolated adipocytes at 20% lipocrit (-200 ,000 cells/ml) were incubated with '25I-insulin (1 X 10-10 M) in the absence and presence of increasing concentrations of unlabeled insulin for 2 h at 220C in 10 mM Hepes-KRB buffer (pH 7.4) containing 3% BSA and 2 mM glu-cose. The cells were separated by centrifugation through silicone oil and the radioactivity counted. The nonspecific binding was consistently < 10% of the total binding and the degradation of '25I-insulin determined by TCA precipitation was also < 10% under assay conditions.
Primary culture of human adipocytes. The culture technique for isolated human adipocytes was a modification ofthe one described for isolated rat adipocytes (37, 38) and a recently described procedure for human adipocytes (39) with minor modifications. After the digestion of adipose tissue and cell isolation, collagenase was removed by washing the cells three times with 3% BSA-medium 199 containing penicillin (100 U/ml) and streptomycin (100 ,ug/ml). The cells were then suspended in the same medium in 1:10 ratio of cells and medium in sterile polypropylene 50-ml conical tubes, loosely closed with screw caps, and incubated at 370C for 24-48 h in a 5% C02-humidified atmosphere.
Exposure ofprimary cultures ofadipocytes with insulin and washing procedure. The isolated adipocytes at 10% lipocrit were cultured in the absence and presence of 1 X 10-'°-and 1 X 10-7-M insulin concentrations for 24 h at 370C in a 5% CO2-humidified atmosphere.
Under these incubation conditions, degradation of 1251-insulin at low as well as high insulin concentrations was < 20% and did not appreciably differ in different experimental groups. At the end of the incubation period, the receptor-bound insulin was dissociated by the modified method of Marshall and Olefsky (22) . The entire washing procedure was carried out at 370C with prewarmed and gassed buffers. First the cells were quickly washed with 3% BSA-medium 199, pH 7.4, and then incubated with 3% BSA-medium 199, pH 7.0, for three 20-min intervals at 370C. After the third incubation, the cells were washed with glucose transport assay buffer (10 mM Hepes-KRB buffer, pH 7.4, containing 3% BSA). This washing procedure effectively removed cell-associated insulin, and allowed the glucose transport system of insulin-stimulated adipocytes to deactivate. The cells from the three groups were then used to determine insulin sensitivity and responsiveness of glucose transport and specific '25I-insulin binding in the presence of varying insulin concentrations.
Statistical analysis. Descriptive statistics (mean±SEM) and comparative statistics (paired and unpaired Student's t test) were performed using a computerized program (Stat View, the graphic statistics for the MacIntosh computer). 
Results
Characterization offreshly isolated adipocytes. Basal and insulin-stimulated glucose transport was compared in freshly isolated adipocytes from nonobese-nondiabetic (control), morbidly obese subjects with normal GTT (obese NGTT), and morbidly obese patients with NIDDM (obese NIDDM) (Fig.  1) . The basal glucose transport, expressed as glucose clearance rate per cell, in obese NGTT and obese NIDDM subjects, was significantly decreased when compared with that in controls (P < 0.05). The maximal response of glucose transport at 1 X 10' M insulin was significantly lower in obese NGTT and obese NIDDM subjects compared with that in controls. The differences in basal and insulin-stimulated glucose transport values between control and obese subjects were even more pronounced when the data were expressed by unit cell surface area or cell volume. Furthermore, the maximal response was also significantly decreased (P < 0.05) in NIDDM subjects when compared with age-, weight-, and sex-matched subjects with normal GTT. When analyzed as percent change above basal glucose transport in response to different insulin concentrations ( Fig. 1, top) , the decrease of insulin responsiveness in obesity and NIDDM was also evident. Although, the 50% effective dose (ED50) of insulin-stimulated glucose transport was similar in control and obese subjects with normal glucose tolerance, it was significantly higher in obese NIDDM subjects. The percent specific '25l-insulin binding per 50,000 adipocytes at tracer concentration was significantly lower in obese NGTT compared with that in nonobese-nondiabetic controls (P < 0.05), but it was not statistically different in the presence ofincreasing concentration of unlabeled insulin (Fig. 2) . However, when the data were expressed by cell surface area, the specific 1251I-insulin binding at every insulin concentration was significantly lower in obese subjects. Thus, insulin receptor density was less on the cell surface of adipocytes from obese subjects in comparison with nonobese controls. The percent specific 125I-insulin binding at various insulin concentrations was further decreased in obese NIDDM, even when the data is expressed by cell number and was also significantly lower in comparison to obese controls (Fig. 2) . The data in freshly isolated adipocytes from this patient population largely confirm other studies on insulin-stimulated glucose transport and insulin binding from obese patients with and without NIDDM (3, 4, 33, 36, (40) (41) (42) (43) (44) We have observed that high BSA concentration in the culture medium and large surface area of cells exposed to the medium as described in the methodology section significantly minimize the disruption of cells during long-term incubation periods. Exposure of adipocytes with low concentrations of collagenase (0.5 mg/ml) during isolation procedure also contributed to minimizing cell disruption during culture. The lysis of fat cells during culture was assessed by comparing the ratio of oil (mainly produced by breakage of fat cells) and total fat cell volume. The lysis was < 5% oftotal cell volume in control, obese NGTT, and obese NIDDM subjects after 24-or 48 -h culture. Fig. 3 subjects. The [14C]leucine incorporation into proteins was similar in fat cells cultured in 10% fetal bovine serum or 3% BSA without fetal bovine serum. The ability to culture human adipocytes in a chemically defined medium offers a distinct advantage over the cells cultured in fetal bovine serum in the presence of complicating hormonal factors.
To further validate our culture system, we have compared insulin binding and glucose transport in freshly isolated and 24-h cultured adipocytes. In control subjects, specific 1251I-insulin binding at different insulin concentrations was similar in freshly isolated or 24-h cultured adipocytes (Fig. 4, top) . Although the percent specific "25I-insulin binding at tracer insulin concentration in 24-h cultured cells decreased slightly in obese NGTT (Fig. 4, middle) and obese NIDDM (Fig. 4 , bottom) subjects, the differences were not significant. Specific '251-insulin binding in the presence of different insulin concentrations was not significantly different in fresh and cultured cells in the two obese groups. There were no significant alterations in either basal or insulin-stimulated glucose transport values in freshly isolated and 24-h cultured adipocytes from two obese groups (Fig. 5, middle and bottom) . Although no significant differences were observed in basal or insulin-stimulated glucose transport between fresh and 24-h cultured adipocytes from control subjects, insulin responsiveness appeared to slightly decrease during culture (Fig. 5, top) . More Figs. 6, 7 , and 8, respectively. In the three study groups, basal glucose transport decreased in cells treated for 24 h with 1 X 10-'°and 1 X l0-7 M insulin, though the differences from buffer-treated cells were significant only in 1 X 10-7 M insulin-treated cells (P < 0.05-0.01 for paired t test). In the three patient groups, insulin-stimulated glucose transport was lower in 1 X 10-'°M insulin-treated cells in comparison with buffer-treated cells, though these differences were not significant. However, this trend in decreased insulin-stimulated glucose transport was evident in cells treated with high insulin (1 X I0O-M). In controls, the percent change above basal in the presence of different insulin concentrations was significantly decreased in 1 X l0-7 M insulintreated cells in comparison with those in buffer-treated cells (P < 0.05, paired t test) (Fig. 6) . In obese NGTT subjects, significant reductions in glucose transport stimulated by different concentrations of insulin in cells previously treated with 1 X lI-`M were observed for net values and percent change above basal glucose transport (Fig. 7) . Similar to nonobese and obese subjects with normal glucose tolerance, treatment of adipocytes from diabetic subjects with 1 X l0-I M insulin resulted in significant reduction in net values, as well as percent change above basal glucose transport in response to different insulin concentrations (Fig. 8) . In addition to decreased insulin responsiveness, we also observed a significant reduction in insulin sensitivity of 1 effect of insulin on specific '251-insulin binding in the presence of different concentrations of unlabeled insulin (Fig. 9) . In all three groups, exposure of adipocytes for 24 h with physiological concentration of insulin (1 X 10-10 M) resulted in a -20% decrease in specific 1251I-insulin binding only at tracer insulin concentration over buffer-treated cells. However, when the cells were treated with 1 X l0-7 M insulin, the decreases in '25I-insulin binding at tracer insulin concentration were more pronounced. In 1 X 10-7 M insulin-treated cells, significant reductions in specific 1251-insulin binding were also observed with respective controls, i.e., buffer-treated cells in the presence ofdifferent concentrations ofunlabeled insulin in control (1.6, 10, 50, and 100 ng/ml insulin), obese NGTT (1.6, 10, 50, 100, and 500 ng/ml insulin), and obese NIDDM (1.6, 10, 50, 100, and 500 ng/ml insulin) subjects. Due to the limitations of Scathard analyses, it may be more appropriate to suggest that insulin-induced down-regulation of insulin binding was mainly due to decrease in receptor number in all three groups.
Discussion
To test the hypothesis that insulin induces insulin resistance in normal cells but improves insulin sensitivity in insulin-resis- tant cells, we have (a) characterized a population of patients with and without varying degrees of insulin resistance with regards to glucose transport and insulin binding in freshly isolated adipocytes; (b) developed a primary culture of human adipocytes that maintains the same degree ofinsulin resistance as do the freshly isolated adipocytes; and (c) tested the effects of a 24-h exposure of physiological and high concentrations of insulin in primary culture of adipocytes from these patient populations.
The data in freshly isolated adipocytes from this patient population largely confirm other studies on insulin action and insulin binding from obese patient with and without NIDDM (3, 4, 33, 36, (40) (41) (42) (43) (44) . The benefits of using cultured adipocytes and human or rat adipose tissue pieces to identify regulatory mechanism(s) of insulin receptors and insulin action is well established (20, 37, 38, (45) (46) (47) (48) (49) . A report using cultured human adipocytes from normal subjects has appeared (39) . However, insulin sensitivity and responsiveness were not established by these investigators (39) . The significance of the cell system described in this report is twofold. First, the cultures of human adipocytes are insulin responsive with regard to glucose transport and metabolism. Second, and most important, adipocytes from normal and insulin-resistant patients maintain the original characteristics offreshly isolated adipocytes in culture. The 24-h insulin exposure ofcultured human adipocytes decreased insulin sensitivity and responsiveness. These decreases are similar in control, obese NGTT, and obese NIDDM patients. Also, the extent of down-regulation of the insulin receptor by insulin under in vitro conditions was similar in the three groups of patients. We have previously proposed that the regulation of the cell surface insulin receptors is one of the many biological actions of insulin (19) . Thus, if a cell is resistant to this function of insulin, the number of insulin receptors might be normal or even high in the presence of hyperinsulinemia. The present study demonstrates that adipocytes which are resistant to insulin with regard to glucose transport are normally responsive to the ability of insulin to down-regulate insulin receptors. Kashiwagi et al. (33) have also demonstrated that adipocytes from NIDDM patients which were resistant to insulin with regard to glucose transport were normally responsive to insulin with regard to inhibition of lipolysis.
Our study does not provide any clue as to the mechanism ofinduced insulin resistance by prolonged exposure to insulin. Clearly, it is not only due to insulin receptor loss. Furthermore, the recent studies by Marshall et al. (38) and Garvey et al. (48, 49) , using rat adipocytes, demonstrate that changes in insulin action may precede any change in insulin binding. We and others have demonstrated in cultured rat hepatocytes (50), adipocytes (51), and hepatoma cells (52) that chronic exposure of cells to insulin decreases the intrinsic activity of the insulin receptor kinase. Furthermore, adipose tissue of similar morbidly obese patients with NIDDM shows a defect in the insulin receptor kinase activity (53) . Thus, insulin-induced resistance may be due to the inactivation ofthe insulin receptor kinase or any ofthe other postinsulin binding events that are believed to be important for the mediation of insulin action (54) (55) (56) (57) .
The different results between previously published reports regarding the improved in vivo (6-9) and in vitro (10, 11) sensitivity to insulin in NIDDM patients after insulin treatment, and the present study demonstrating a worsening of insulin resistance by insulin in cultured adipocytes of NIDDM patients, is of interest. The different duration of insulin exposure could be the explanation. However, it seems appropriate to speculate that for insulin to have a beneficial effect on insulin sensitivity, the interaction with other hormones or factors that are absent in serum-free medium may be crucial. Furthermore, it may not be insulin per se, but another factor that is induced by insulin in NIDDM patients that may be enhancing insulin sensitivity. Amatruda et al. (58) have previously shown that in nonketotic streptozotocin diabetic rats administration of insulin improved insulin action in the liver. In contrast, in vitro insulin exposure of primary cultures of hepatocytes from these same diabetic insulin-resistant animals did not result in an improved insulin response (58) . The factor(s) that regulate insulin action are largely unknown. However, the cell model described here with human cells in culture from normal and insulin-resistant subjects should facilitate the search of the mechanism(s) that modulate insulin action in man.
